Hyasynth Bio's Convertible Note Round

Hyasynth Bio raised a round of funding on September 13, 2018. Investors include Organigram.

Hyasynth Bio is a company that manufactures natural cannabinoid compounds without the use of cannabis plants. Hyasynth's technology uses engineered yeast to produce cannabinoids through scalable ferme…

Articles about Hyasynth Bio's Convertible Note Round: